BSEM News and Press, BioStem Technologies Inc

Miami, Florida--(Newsfile Corp. - July 16, 2024) - Innovation is the lifeblood of the MedTech sector. Literally. Discoveries made are more than value drivers for the companies behind them; they can be life savers to millions needing better and more effective healthcare solutions. While that need ...

POMPANO BEACH, Fla., July 10, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, announces that the IRB has approved a clinic...

POMPANO BEACH, Fla., June 26, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, today announced that an article validating ...

Please note: this Update is being issued for ticker indexing purposes. The content of the release itself remains the same. NEW YORK, June 17, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive interview with Jason Matuszewski, CEO of BioStem Technologies, Inc. ( OTC: BSE...

POMPANO BEACH, Fla., May 29, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics, will sponsor the MRO Better Half Dash which will be held on May 29, 2...

(NewsDirect) Regenerative medicine is revolutionizing healthcare. It encompasses a range of cutting-edge therapies aimed at repairing or replacing damaged tissues and organs, offering tangible solutions rather than mere symptom management. With a global market projected to surge from USD 29.4...

2024-05-15 09:39:59 ET More on BioStem Technologies Biostem Technologies, Inc. (BSEM) Q1 2024 Earnings Call Transcript Biostem Technologies, Inc. (BSEM) Q4 2023 Earnings Call Transcript Read the full article on Seeking Alpha For further details see: BioSt...

2024-05-14 21:50:24 ET Biostem Technologies, Inc. (BSEM) Q1 2024 Earnings Conference Call May 14, 2024 04:30 PM ET Company Participants Jeff Ramson - IR, PCG Advisory Group Jason Matuszewski - Chief Executive Officer Mike Fortunato - Chief Financial Officer ...

- Company Achieves Record-Breaking First Quarter Results for 2024, Marking the Launch of BioStem 2.0 - - Company Reports First Quarter EBITDA of $4.9 Million - - Project Continued Growth from Sales of AmnioWrap2 ® - - Financial Results Conference Call and Webcas...

POMPANO BEACH, Fla., May 07, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading biotechnology company focused on the development, manufacture, and commercialization of placental derived allografts for advanced wound care, announced today that it plans to release its first q...